These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19514366)

  • 101. The role of ultrasound and tumour markers in the early detection of ovarian cancer.
    Oram DH; Jeyarajah AR
    Br J Obstet Gynaecol; 1994 Nov; 101(11):939-45. PubMed ID: 7999723
    [No Abstract]   [Full Text] [Related]  

  • 102. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Progress in the study of normal-sized ovary carcinoma syndrome].
    Zeng DY; Shen J
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1149-51. PubMed ID: 16029582
    [No Abstract]   [Full Text] [Related]  

  • 104. Ovarian carcinoma pathology and genetics: recent advances.
    Gilks CB; Prat J
    Hum Pathol; 2009 Sep; 40(9):1213-23. PubMed ID: 19552940
    [TBL] [Abstract][Full Text] [Related]  

  • 105. High-grade serous carcinoma of the ovary.
    Westfall D; Roma AA; Silva EG
    Ann Diagn Pathol; 2009 Aug; 13(4):285-90. PubMed ID: 19608089
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A pure nongestational ovarian choriocarcinoma in a 10-year-old girl: case report and literature review.
    Kong B; Tian YJ; Zhu WW; Qin YJ
    J Obstet Gynaecol Res; 2009 Jun; 35(3):574-8. PubMed ID: 19527404
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Carcinosarcoma of the ovary a review.
    Cantrell LA; Van Le L
    Obstet Gynecol Surv; 2009 Oct; 64(10):673-80; quiz 697. PubMed ID: 19772676
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 109. eEF1A2 as a putative oncogene.
    Lee MH; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():87-93. PubMed ID: 19723040
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Brenner's tumor].
    de Brux J; L'Orphelin C; Robey M; Taurelle R
    Rev Fr Gynecol Obstet; 1973 Feb; 68(2):129-36. PubMed ID: 17471695
    [No Abstract]   [Full Text] [Related]  

  • 111. [Ovarian carcinoma: certain characteristics of evolution, advancement and diagnosis].
    Prokopenko PG; Terent'ev AA
    Vopr Onkol; 2009; 55(2):143-50. PubMed ID: 19514366
    [No Abstract]   [Full Text] [Related]  

  • 112. [Tumour markers in epithelial ovarian cancer].
    Sparholt MH; Høgdall E; Høgdall CK
    Ugeskr Laeger; 2009 Nov; 171(48):3505-9. PubMed ID: 19944049
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Clinical decision making using ovarian cancer risk assessment.
    Stany MP; Maxwell GL; Rose GS
    AJR Am J Roentgenol; 2010 Feb; 194(2):337-42. PubMed ID: 20093593
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A review and an update on the screening of epithelial ovarian cancer.
    Reynolds EA; Moller KA
    Curr Probl Cancer; 2006; 30(5):203-32. PubMed ID: 16996383
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 6.